CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

MK0966; Rofecoxib / Duration of Treatment: 156 weeks - Phase 3 | MRK Pipeline | CatalystAlert